Neurological & CognitiveLimited ResearchSupplement / Drug (region-dependent)C

CDP-Choline

Citicoline

Last reviewed . First published . By the PeptIQ team.

Educational and observational reference only. Not medical advice. Community charts may use modeled aggregates when live snapshots are unavailable.

Studies cited
5
Research grade
C
Experience
73

Overall check-ins

Activity
67

Trackers & reports

Typical Dose

Varies by protocol

Route

Oral

Cycle

Protocol-dependent

Storage

Room Temperature

What is CDP-Choline?

Choline donor and nootropic compound used for cognitive and neuro-support protocols (non-peptide).

Research Indications

Cognitive FunctionEffective

Research suggests improvements in memory, focus, and cognitive processing

NeuroprotectionModerate

May protect neurons from oxidative stress and inflammatory damage

Mood & AnxietyModerate

Some studies report anxiolytic and mood-stabilizing effects

Research Protocols

These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.

GoalDoseFrequencyRoute
Starting DoseLow doseOnce dailyIntranasal or Injectable
Standard DoseStandardOnce dailyIntranasal or Injectable

Peptide & Drug Interactions

Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.

Stimulants (Modafinil, Adderall)Caution
MAOIs / SSRIsMonitor
RacetamsCaution
NAD+Compatible
BPC-157Compatible

How to Reconstitute & Inject

Use bacteriostatic (BAC) water only. Avoid saline — may cause precipitation. Refrigerate and use within 28 days.

  1. 1

    Remove CDP-Choline vial from refrigeration and allow to reach room temperature (15–20 minutes)

  2. 2

    Clean vial top with alcohol swab and allow to air dry completely

  3. 3

    Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water)

  4. 4

    Inject BAC water slowly down the side of the vial — do not aim directly at the powder

  5. 5

    Gently swirl in circular motions — DO NOT shake vigorously as this degrades the peptide

  6. 6

    Allow 2–3 minutes for full dissolution — solution should be clear and colorless

  7. 7

    Draw calculated dose into an insulin syringe for subcutaneous injection

  8. 8

    Inject into abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy

  9. 9

    Store reconstituted solution refrigerated (2–8°C) and use within 28 days

What to Expect

Week 1–2

Subtle mood and focus improvements may begin. Sleep quality often improves early.

Week 2–4

Increased mental clarity, word recall, and reduced brain fog reported by many.

Week 4–8

Consistent cognitive improvements. Better stress response and working memory.

Week 8+

Sustained cognitive and neurological benefits. Effects may persist post-cycle.

Side Effects & Safety

  • Headache, particularly at initiation
  • Mild anxiety or restlessness with some compounds
  • Nasal irritation (intranasal administration)
  • Sleep disturbance if dosed too close to bedtime
  • Rare: Mood changes or emotional lability

FDA Status & Regulatory Info

Supplement / Drug (region-dependent)

Choline donor and nootropic compound used for cognitive and neuro-support protocols (non-peptide).

Rx Required: No
503A Ban: No
Telehealth: Available
Full FDA Status Tracker

Frequently Asked Questions

Community-reported data

The information below reflects self-reported experiences from PeptIQ app users. It is not clinical evidence and should not replace professional medical advice.

What 208 users report

Observational self-reports (modeled when live data is unavailable). Not clinical outcomes.

208 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 52% · Mixed 36% · Unfavorable overall 12%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Mood
159
Focus
52
Sleep quality
152
Lean mass
119
Joint comfort
115

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Fatigue
75
Nausea
132
Water retention
117
Appetite loss
115
Injection site reaction
114

Self-reported dose per injection

Median bucket: 0.2–0.4 mg · Most common: 0.1–0.2 mg

Reports span 0.01–2 mg

0.01–0.025 mg
8
0.025–0.05 mg
17
0.05–0.1 mg
25
0.1–0.2 mg
28
0.2–0.4 mg
19
0.4–0.6 mg
11
0.6–1 mg
8
1–2 mg
3

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing12stacking25side effects18cdp-choline16

How repeat users are trending

Among repeat reporters, 62% said they felt similar to their last entry, 32% more positive, and 12% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 15 days · Based on 46 repeat reporters

Share Your Experience

Rate CDP-Choline in the PeptIQ app and help the community make informed decisions.

Research References (4)

Cited PubMed, trial registry, and label sources for education only. We do not control third-party content.

  1. PubMed

    Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)

    Davalos A, Alvarez-Sabin J, Castillo J, et al. Lancet. 2012

    Source
    Wiki study page →
  2. PubMed

    Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT)

    Zafonte RD, Bagiella E, Ansel BM, et al. JAMA. 2012

    Source
    Wiki study page →
  3. ClinicalTrials.gov

    International Citicoline Trial on Acute Stroke (ICTUS) (NCT00331890)

    ClinicalTrials.gov. Clinical trial registry. 2006

    Source
    Wiki study page →
  4. ClinicalTrials.gov

    Citicoline Brain Injury Treatment Trial (COBRIT) (NCT00545662)

    ClinicalTrials.gov. Clinical trial registry. 2007

    Source
    Wiki study page →

Wiki tools

Observational indexes and compare views for CDP-Choline.

Educational information only

This page is for educational reference. It is not medical or legal advice. PeptIQ does not sell peptides or list vendors. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.

PeptIQ app

Log your CDP-Choline protocol in PeptIQ

Turn this CDP-Choline guide into a living protocol — doses, vials, and history in one place.

Track CDP-CholineOpen web app

iOS, Android, and web

Ask PeptIQ

Two taps on our guided quiz, then keep going in iMessage with sources — not Instagram screenshots.

Start the quizOr try Peptide X Quiz →

Quick Facts

Route
Oral
Availability
Varies
Rx Required
No
503A Ban
No
Browse peptide education

Talk with a clinician

PeptIQ is education only. We do not sell peptides or list vendors. Discuss CDP-Choline with a licensed healthcare provider — not medical advice, not a prescription.

Download PeptIQ

Wiki tools

Observational indexes and compare views for CDP-Choline.